Saccharomyces cerevisiae, along with other eukaryotes, is resistant to tetracyclines. We found that deletion of SOD1 (encoding Cu/Zn superoxide dismutase) rendered S. cerevisiae hypersensitive to oxytetracycline (OTC): a sod1⌬ mutant exhibited a >95% reduction in colony-forming ability at an OTC concentration of 20 g ml ؊1 , whereas concentrations of up to 1,000 g ml ؊1 had no effect on the growth of the wild type. OTC resistance was restored in the sod1⌬ mutant by complementation with wild-type SOD1. The effect of OTC appeared to be cytotoxic and was not evident in a ctt1⌬ (cytosolic catalase) mutant or in the presence of tetracycline. SOD1 transcription was not induced by OTC, suggesting that constitutive SOD1 expression is sufficient for wild-type OTC resistance. OTC uptake levels in wild-type and sod1⌬ strains were similar. However, lipid peroxidation and protein oxidation were both enhanced during exposure of the sod1⌬ mutant, but not the wild type, to OTC. We propose that Sod1p protects S. cerevisiae against a mode of OTC action that is dependent on oxidative damage.Reactive oxygen species (ROS) are generated during normal cellular respiratory metabolism, but their damaging effects are generally suppressed by antioxidant defenses. Protective enzymes operating in the budding yeast Saccharomyces cerevisiae are well characterized (30); these include superoxide dismutases (SODs) and catalases, which specifically protect against O 2 ⅐ Ϫ and H 2 O 2 , respectively. S. cerevisiae mutants lacking the principal cellular SOD (Cu/Zn SOD; encoded by SOD1) display certain aerobic growth defects, e.g., reduced growth rate, and methionine and lysine auxotrophies (4). Moreover, sod1⌬ strains are hypersensitive to several types of stress, including oxidative stress (16), metal toxicity (6, 36), prolonged stationary incubation (24), and freeze-thaw stress (28). Such evidence has underscored the central role of ROS in mediating various stresses. However, there is presently no evidence to suggest that antioxidant defenses play a role in the insensitivity of eukaryotes, such as S. cerevisiae, to the action of prokaryotespecific antibiotics.The tetracyclines (e.g., tetracycline, doxycycline, and oxytetracycline [OTC]) are classic broad-spectrum bacteriostatic antibiotics. They are commonly thought to act by inhibiting protein synthesis, through inhibition of binding by aminoacyltRNA to the ribosomal A site (22). Although binding of the tetracyclines to eukaryotic ribosomes occurs in vitro, the in vivo insensitivity of eukaryotes to these antibiotics is usually considered a reflection of the inaccessibility of tetracyclines to the eukaryotic intracellular environment (19); genes conferring OTC resistance to prokaryotes generally encode OTC export proteins (18, 32). The generality of fungal tetracycline resistance is exemplified by the use of OTC in fungiselective growth media (Difco manual, Difco, Detroit, Mich.) and the opportunistic yeast infections that commonly arise following tetracycline administration to humans (22).Inhib...